Meropenem and vaborbactam

(Vabomere)

Meropenem and vaborbactam

Drug updated on 11/14/2023

Dosage FormInjection (intravenous: 2 g/vial (1 g meropenem (equivalent to 1.14 g meropenem trihydrate) and 1 g vaborbactam))
Drug ClassMultiple
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated for the treatment of patients 18 years and older with complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible bacteria.